#RiskStratification May Work Well for FIT-Based #CRC Screening in Elderly tinyurl.com/3mrwe4pd @MDEdgeHemOnc #ColorectalCancer

#FDA Expands #Darzalex Faspro Indication in #Myeloma 👉tinyurl.com/5aajvb8t @MDEdgeHemOnc #Survival

#BlackWomen With #BreastCancer Face Clinical Inequities 👉tinyurl.com/yc5ujwrs @MDEdgeHemOnc #PIK3CA

#LBCL: #CART Benefits Both Young and Old 👉tinyurl.com/2v7jvswj @MDEdgeHemOnc #Cancer

#Cannabis Overuse Linked to Increased Risk for #HeadandNeck Cancer 👉tinyurl.com/42emyy53 @MDEdgeHemOnc #ENT

#FDA Approves #Axatilimab for Chronic GVHD 👉tinyurl.com/ykad5mpe @MDEdgeHemOnc #GraftVSHost

#BRCA Mutations in Men: Important but Often Overlooked 👉tinyurl.com/2p832eyn @MDEdgeHemOnc

Diagnosing, Treating #Rashes In Patients on #ImmuneCheckpointInhibitors 👉tinyurl.com/4sp5c8k9 @MDEdgeHemOnc #ICI

Aspirin for #CRC Prevention May Work Best in Adults With Unhealthy #Lifestyles 👉tinyurl.com/mt3aas9k @MDEdgeHemOnc #BMI #Aspirin

#Cancer Cases, Deaths in Men Predicted to Surge by 2050 👉tinyurl.com/bddnvbh4 @MDEdgeHemOnc #GLOBOCAN

#SBRT vs #Surgery in #CRC #LungMetastases: Which Is Better? 👉tinyurl.com/mkua4yxx @MDEdgeHemOnc #Oligometastases

#Olanzapine Eases Chemo-Induced #Nausea and #Vomiting 👉tinyurl.com/2s46s8az @MDEdgeHemOnc #Antipsychotic

#FalsePositive #Mammography Results Linked to Reduced Rates of Future Screenings 👉tinyurl.com/4km6kmd5 @MDEdgeHemOnc #BreastCancerSurveillance

Do Clonal #Hematopoiesis and #MosaicChromosomal Alterations Increase #SolidTumor Risk? 👉tinyurl.com/yexh4zyz @MDEdgeHemOnc #CHIP #mCA

To Choose the Best First-line Drug for #CML, Consider Efficacy and Cost 👉tinyurl.com/4849ue72 @MDEdgeHemOnc #TyrosineKinaseInhibitor

#BreastCancer Hormone Therapy May Protect Against #Dementia 👉tinyurl.com/yc4dkdn7 @MDEdgeHemOnc #Medicare

Debate: Should #CART Best Be Used in Early #MM Relapse? 👉tinyurl.com/2s43jmtw @MDEdgeHemOnc #SocietyofHematologicOncology

#KRASInhibitors in #PancreaticCancer: Hope on the Horizon? 👉tinyurl.com/mte82hkc @MDEdgeHemOnc #Oncogene

No Matched #Sibling Donor? #SickleCell Experts Debate Next-Best Option 👉tinyurl.com/29dck52c @MDEdgeHemOnc #SOHO #SCD

#FDA OKs Subcutaneous #Atezolizumab Formulation for Multiple #Cancer Indications 👉tinyurl.com/528sru7h @MDEdgeHemOnc #NSCLC #SCLC